France: Sofinnova Partners closes early-stage healthcare venture capital fund at €472m

Antoine Papiernik, managing partner, Sofinnova Partners

Sofinnova Partners, a leading European life sciences VC firm based in Paris, London and Milan, has closed its latest early-stage healthcare venture capital fund, Sofinnova Capital X, oversubscribed at €472m (US$548m). This brings the total amount the VC has raised to €1bn in the last 12 months across its multi-fund platform, and the total AUM…

You must be a HMI Subscriber to view this content.

Subscribe Now »